发明名称 OPTIMIZED Fc VARIANTS
摘要 PROBLEM TO BE SOLVED: To provide an antibody comprising a polypeptide having a variant Fc region with increased binding to FcRn, the antibody having a low rate of clearance in blood circulation.SOLUTION: There is provided a method for making a phage library including a group of variants from the human antibody Fc gene and performing screening using the binding to FcRn as an indicator. By the method, Fc variants exhibiting high binding to FcRn, particularly amino acid modification sites thereof, are determined, and anti-CD20 antibody human IgG is reconstructed using the Fc variants. The anti-CD20 antibody human IgG exhibits ADCC activity to chronic lymphocytic leukaemia cells.
申请公布号 JP2016014020(A) 申请公布日期 2016.01.28
申请号 JP20150126168 申请日期 2015.06.24
申请人 LAB FRANCAIS DU FRACTIONNEMENT & DES BIOTECHNOLOGIES 发明人 CHRISTIAN BEHRENS;SYLVIE JORIEUX;ABDELHAKIM KHARRAT;KHALIL BOUAYADI;PHILIPPE MONDON;CELINE MONNET-MARS
分类号 C07K16/00;A61K39/395;A61P1/04;A61P11/06;A61P19/02;A61P25/00;A61P29/00;A61P31/00;A61P35/00;A61P35/02;A61P37/00;A61P37/06;A61P37/08;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N15/09;C12P21/08 主分类号 C07K16/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利